TFDA Labeling Deadline June 20, 2026: Final Compliance Checklist for Foreign Manufacturers

On June 20, 2026, Thailand's new medical device labeling and Instructions for Use regulation, Notification B.E. 2568, takes formal effect. The Ministry of Public Health finalized this regulation on December 22, 2025, giving the industry six months to prepare. That window closes in 19 days.

We covered the substance of the new requirements in depth in our April article when there was still time to plan. This article is a status check. The question now is not what the regulation says. The question is whether your labels, IFUs, and internal documentation processes are actually ready for a Thai FDA inspection or an international buyer audit that happens after June 20.

What B.E. 2568 Changes

Three changes from the 2020 labeling framework carry the highest operational impact for foreign manufacturers.

Mandatory content expanded. Labels must now include, at minimum: the product name, manufacturer name and address, local importer name and address, intended use or indications, TFDA registration number, lot or batch number, manufacturing or expiry date where applicable, and storage conditions. For reusable devices, maximum sterilization cycles and inter-use storage conditions are now mandatory on the label. These were optional or inconsistently required under the 2020 rules.

Language requirements clarified by device type. Home-use devices require Thai-language labels. Professional-use devices may carry Thai or English. For Software as a Medical Device used by professionals, a Thai-language summary of intended use is now required, with the full English IFU acceptable as a supplement. Manufacturers relying on English-only labels for home-use products need to correct this before June 20.

Import labeling timeline shortened from 180 to 120 days. Importers now have 120 days from customs clearance to complete Thai-language labeling. For operations running lean inventory cycles, this 60-day compression needs to be built into receiving and warehousing SOPs if it has not been already.

The Transition Period: What It Covers and What It Does Not

The regulation includes a two-year transition period running from June 20, 2026 to June 20, 2028. This provision is frequently misunderstood.

What it covers: devices already bearing 2020-compliant labels that have been imported and cleared customs before June 20. That existing inventory may continue to be sold in Thailand without relabeling through June 2028.

What it does not cover: any new registration submitted after June 20, 2026. Any variation application, change notification, or renewal filed after the deadline is evaluated under B.E. 2568, not the 2020 rules. If you have a registration renewal currently under review that will not be resolved before June 20, the documentation you submitted may need to be updated before Thai FDA approves it. Confirm this with your local authorized representative now.

Pre-Deadline Compliance Checklist

Label content audit. For each Thai-registered product, verify the physical label includes all mandatory content elements under B.E. 2568. Pay specific attention to the TFDA registration number appearing on the physical label (not only in documentation), and for reusable devices, sterilization cycle limits.

Home-use vs. professional-use classification. Confirm Thai FDA's classification for each product. If any home-use devices currently carry English-only labels, this must be corrected before June 20 or the product is non-compliant from day one of the new regime.

SaMD IFU review. If you have Software as a Medical Device registered for professional use in Thailand, confirm a Thai-language summary of intended use exists and is accessible alongside your English IFU.

Import labeling workflow update. Confirm with your Thai importer that SOPs and any 3PL agreements have been updated to reflect the 120-day labeling window from customs clearance.

Pending submissions review. Identify any registrations, renewals, or variation applications currently under TFDA review that will not be resolved before June 20. Discuss with your local authorized representative whether documentation updates to meet B.E. 2568 are needed before those submissions can be approved.

Annual report confirmation. Note that the Thai FDA also moved the annual post-market surveillance report deadline from March 31 to May 31, effective March 2026. The first affected deadline under the new date was May 31, 2026. Confirm with your Thai representative that all required annual reports were filed on time.

The Change Notification Dimension

One issue that has not received enough attention: if you are updating labels specifically to comply with B.E. 2568, that update may itself trigger a change notification obligation under Thailand's medical device change notification framework.

In March 2026, the Thai FDA issued a new consolidated change notification guideline replacing the 2022 and 2025 editions. Under the new three-tier system (auto-approval, minor change, major change), most labeling updates made for B.E. 2568 compliance will qualify as minor changes. However, if the update also modifies intended use language or changes how the device is described relative to its classification, a major change notification may be required. Confirm the correct tier with your local representative before printing new packaging or filing.

DeeMED's Thai FDA regulatory consulting team manages labeling compliance reviews, change notification preparation, and TFDA submission management for foreign manufacturers. If you are uncertain where your registered products stand ahead of June 20, contact us now while there is still time to act.